Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2013

Open Access 01-12-2013 | Original investigation

Urinary adiponectin concentration is positively associated with micro- and macro-vascular complications

Authors: Won Seon Jeon, Ji Woo Park, Namseok Lee, Se Eun Park, Eun Jung Rhee, Won Young Lee, Ki Won Oh, Sung Woo Park, Cheol-Young Park, Byung-Soo Youn

Published in: Cardiovascular Diabetology | Issue 1/2013

Login to get access

Abstract

Background

A relationship between plasma adiponectin level and a number of metabolic conditions, including insulin resistance, obesity, and type 2 diabetes, has been reported. This study aimed to assess whether urinary adiponectin concentration is correlated with vascular complications.

Methods

The study comprised 708 subjects who enrolled in the Seoul Metro City Diabetes Prevention Program and were carefully monitored from September 2008 to December 2008. Levels of urinary adiponectin were measured using an enzyme linked immunosorbent assay (ELISA) kit (AdipoGen, Korea). Urinary albumin excretion was assessed by the ratio of urinary albumin to creatinine (A/C ratio). Participants were divided into three groups based on tertiles of urinary adiponectin concentration, and we investigated whether urinary adiponectin levels are associated with microalbuminuria and pulse wave velocity.

Results

Urinary adiponectin concentrations were significantly higher in subjects with microalbuminuria than subjects with normoalbuminuria (P < 0.001). Urinary adiponectin concentration was positively correlated with age, fasting plasma glucose level, HbA1C level, triglyceride level, HOMA-IR, systolic/diastolic blood pressure, and urinary A/C ratio (all P < 0.05). Subjects in the highest tertile of urinary adiponectin concentration had an increased likelihood of microalbuminuria than those in the lowest tertile (Odds ratio (OR), 6.437; 95% confidence interval (CI), 4.202 to 9.862; P < 0.001). After adjusting for age, sex, and estimated creatinine clearance rate (eCcr), the OR remained significant (OR, 5.607; 95% CI, 3.562 to 8.828; P < 0.001). Backward multiple linear regression analysis revealed urinary adiponectin concentration to be a significant determinant of mean brachial-ankle pulse wave velocity (baPWV).

Conclusions

An increased urinary adiponectin concentration is significantly associated with microalbuminuria and increased mean baPWV. These results suggest that urinary adiponectin may play an important role as a biomarker for vascular dysfunction.
Literature
1.
go back to reference Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995, 270: 26746-26749. 10.1074/jbc.270.45.26746.CrossRefPubMed Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995, 270: 26746-26749. 10.1074/jbc.270.45.26746.CrossRefPubMed
2.
go back to reference Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T: Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes care. 2003, 26: 2015-2020. 10.2337/diacare.26.7.2015.CrossRefPubMed Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T: Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes care. 2003, 26: 2015-2020. 10.2337/diacare.26.7.2015.CrossRefPubMed
3.
go back to reference Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, et al: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Comm. 1999, 257: 79-83. 10.1006/bbrc.1999.0255.CrossRefPubMed Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, et al: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Comm. 1999, 257: 79-83. 10.1006/bbrc.1999.0255.CrossRefPubMed
4.
go back to reference Park JY, Kim JW, Kim JM, Han Y, Park SK, Mok JY, Park MK, Lee HJ, Kim DK: Adiponectin concentrations in type 2 diabetic patients with or without metabolic syndrome. Korean diabetes journal. 2008, 32: 224-235. 10.4093/kdj.2008.32.3.224.CrossRef Park JY, Kim JW, Kim JM, Han Y, Park SK, Mok JY, Park MK, Lee HJ, Kim DK: Adiponectin concentrations in type 2 diabetic patients with or without metabolic syndrome. Korean diabetes journal. 2008, 32: 224-235. 10.4093/kdj.2008.32.3.224.CrossRef
5.
go back to reference Saraheimo M, Forsblom C, Fagerudd J, Teppo AM, Pettersson-Fernholm K, Frystyk J, Flyvbjerg A, Groop PH: Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes care. 2005, 28: 1410-1414. 10.2337/diacare.28.6.1410.CrossRefPubMed Saraheimo M, Forsblom C, Fagerudd J, Teppo AM, Pettersson-Fernholm K, Frystyk J, Flyvbjerg A, Groop PH: Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes care. 2005, 28: 1410-1414. 10.2337/diacare.28.6.1410.CrossRefPubMed
6.
go back to reference Amin R, Frystyk J, Ong K, Dalton RN, Flyvbjerg A, Dunger DB: The development of microalbuminuria is associated with raised longitudinal adiponectin levels in female but not male adolescent patients with type 1 diabetes. Diabetologia. 2008, 51: 1707-1713. 10.1007/s00125-008-1081-1.CrossRefPubMed Amin R, Frystyk J, Ong K, Dalton RN, Flyvbjerg A, Dunger DB: The development of microalbuminuria is associated with raised longitudinal adiponectin levels in female but not male adolescent patients with type 1 diabetes. Diabetologia. 2008, 51: 1707-1713. 10.1007/s00125-008-1081-1.CrossRefPubMed
7.
go back to reference Youn JC, Kim C, Park S, Lee SH, Kang SM, Choi D, Son NH, Shin DJ, Jang Y: Adiponectin and progression of arterial stiffness in hypertensive patients. Int J Cardiol. 2013, 163 (3): 316-319. 10.1016/j.ijcard.2011.06.061.CrossRefPubMed Youn JC, Kim C, Park S, Lee SH, Kang SM, Choi D, Son NH, Shin DJ, Jang Y: Adiponectin and progression of arterial stiffness in hypertensive patients. Int J Cardiol. 2013, 163 (3): 316-319. 10.1016/j.ijcard.2011.06.061.CrossRefPubMed
8.
go back to reference Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Katho T, Ohtsuka N: Serum high molecular weight adiponectin correlates with arterial stiffness in community-dwelling persons. Endocr Res. 2011, 36: 53-63. 10.3109/07435800.2010.534754.CrossRefPubMed Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Katho T, Ohtsuka N: Serum high molecular weight adiponectin correlates with arterial stiffness in community-dwelling persons. Endocr Res. 2011, 36: 53-63. 10.3109/07435800.2010.534754.CrossRefPubMed
9.
go back to reference Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, et al: Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. JASN. 2002, 13: 134-141.CrossRefPubMed Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, et al: Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. JASN. 2002, 13: 134-141.CrossRefPubMed
10.
go back to reference Seon CS, Min KW, Lee SY, Nho KW, Park SH, Koo BK, Han KA: Cardiovascular risk assessment with vascular function, carotid atherosclerosis and the UKPDS risk engine in Korean patients with newly diagnosed type 2 diabetes. J Diabetes Metabol. 2011, 35: 619-627. 10.4093/dmj.2011.35.6.619.CrossRef Seon CS, Min KW, Lee SY, Nho KW, Park SH, Koo BK, Han KA: Cardiovascular risk assessment with vascular function, carotid atherosclerosis and the UKPDS risk engine in Korean patients with newly diagnosed type 2 diabetes. J Diabetes Metabol. 2011, 35: 619-627. 10.4093/dmj.2011.35.6.619.CrossRef
11.
go back to reference von Eynatten M, Liu D, Hock C, Oikonomou D, Baumann M, Allolio B, Korosoglou G, Morcos M, Campean V, Amann K, et al: Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes. Diabetes. 2009, 58: 2093-2099. 10.2337/db09-0204.PubMedCentralCrossRefPubMed von Eynatten M, Liu D, Hock C, Oikonomou D, Baumann M, Allolio B, Korosoglou G, Morcos M, Campean V, Amann K, et al: Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes. Diabetes. 2009, 58: 2093-2099. 10.2337/db09-0204.PubMedCentralCrossRefPubMed
12.
go back to reference Koshimura J, Fujita H, Narita T, Shimotomai T, Hosoba M, Yoshioka N, Kakei M, Fujishima H, Ito S: Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Comm. 2004, 316: 165-169. 10.1016/j.bbrc.2004.02.032.CrossRefPubMed Koshimura J, Fujita H, Narita T, Shimotomai T, Hosoba M, Yoshioka N, Kakei M, Fujishima H, Ito S: Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Comm. 2004, 316: 165-169. 10.1016/j.bbrc.2004.02.032.CrossRefPubMed
13.
go back to reference Won JC, Park CY, Park HS, Kim JH, Choi ES, Rhee EJ, Lee WY, Oh KW, Kim SW, Park SW: 1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes. Diabetes Res Clin Pract. 2009, 84: 51-57. 10.1016/j.diabres.2009.01.002.CrossRefPubMed Won JC, Park CY, Park HS, Kim JH, Choi ES, Rhee EJ, Lee WY, Oh KW, Kim SW, Park SW: 1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes. Diabetes Res Clin Pract. 2009, 84: 51-57. 10.1016/j.diabres.2009.01.002.CrossRefPubMed
14.
go back to reference Park SE, Kim WJ, Park SW, Park JW, Lee N, Park CY, Youn BS: High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria. Eur J Endocrinol. 2013, 168: 203-210. 10.1530/EJE-12-0782.CrossRefPubMed Park SE, Kim WJ, Park SW, Park JW, Lee N, Park CY, Youn BS: High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria. Eur J Endocrinol. 2013, 168: 203-210. 10.1530/EJE-12-0782.CrossRefPubMed
15.
go back to reference American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes care. 2005, 28 (Suppl 1): S37-S42.CrossRef American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes care. 2005, 28 (Suppl 1): S37-S42.CrossRef
16.
go back to reference Yaturu S, Reddy RD, Rains J, Jain SK: Plasma and urine levels of resistin and adiponectin in chronic kidney disease. Cytokine. 2007, 37: 1-5. 10.1016/j.cyto.2007.02.003.CrossRefPubMed Yaturu S, Reddy RD, Rains J, Jain SK: Plasma and urine levels of resistin and adiponectin in chronic kidney disease. Cytokine. 2007, 37: 1-5. 10.1016/j.cyto.2007.02.003.CrossRefPubMed
17.
go back to reference Shen YY, Hughes JT, Charlesworth JA, Kelly JJ, Peake PW: Adiponectin is present in the urine in its native conformation, and specifically reduces the secretion of MCP-1 by proximal tubular cells. Nephrology (Carlton). 2008, 13: 405-410. 10.1111/j.1440-1797.2008.00949.x.CrossRef Shen YY, Hughes JT, Charlesworth JA, Kelly JJ, Peake PW: Adiponectin is present in the urine in its native conformation, and specifically reduces the secretion of MCP-1 by proximal tubular cells. Nephrology (Carlton). 2008, 13: 405-410. 10.1111/j.1440-1797.2008.00949.x.CrossRef
18.
go back to reference Hunt KJ, Williams K, Rivera D, O’Leary DH, Haffner SM, Stern MP, Gonzalez Villalpando C: Elevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes. Arterioscler Thromb Vasc Biol. 2003, 23: 1845-1850. 10.1161/01.ATV.0000093471.58663.ED.CrossRefPubMed Hunt KJ, Williams K, Rivera D, O’Leary DH, Haffner SM, Stern MP, Gonzalez Villalpando C: Elevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes. Arterioscler Thromb Vasc Biol. 2003, 23: 1845-1850. 10.1161/01.ATV.0000093471.58663.ED.CrossRefPubMed
19.
go back to reference Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, et al: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001, 286: 421-426. 10.1001/jama.286.4.421.CrossRefPubMed Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, et al: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001, 286: 421-426. 10.1001/jama.286.4.421.CrossRefPubMed
20.
go back to reference Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, et al: Adiponectin regulates albuminuria and podocyte function in mice. The Journal of clinical investigation. 2008, 118: 1645-1656.PubMedCentralPubMed Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, et al: Adiponectin regulates albuminuria and podocyte function in mice. The Journal of clinical investigation. 2008, 118: 1645-1656.PubMedCentralPubMed
21.
go back to reference Ohashi K, Iwatani H, Kihara S, Nakagawa Y, Komura N, Fujita K, Maeda N, Nishida M, Katsube F, Shimomura I, et al: Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol. 2007, 27: 1910-1917. 10.1161/ATVBAHA.107.147645.CrossRefPubMed Ohashi K, Iwatani H, Kihara S, Nakagawa Y, Komura N, Fujita K, Maeda N, Nishida M, Katsube F, Shimomura I, et al: Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol. 2007, 27: 1910-1917. 10.1161/ATVBAHA.107.147645.CrossRefPubMed
22.
go back to reference Shimotomai T, Kakei M, Narita T, Koshimura J, Hosoba M, Kato M, Komatsuda A, Ito S: Enhanced urinary adiponectin excretion in IgA-nephropathy patients with proteinuria. Renal failure. 2005, 27: 323-328.CrossRefPubMed Shimotomai T, Kakei M, Narita T, Koshimura J, Hosoba M, Kato M, Komatsuda A, Ito S: Enhanced urinary adiponectin excretion in IgA-nephropathy patients with proteinuria. Renal failure. 2005, 27: 323-328.CrossRefPubMed
23.
go back to reference Mahmud A, Feely J: Adiponectin and arterial stiffness. Am J Hypertens. 2005, 18: 1543-1548. 10.1016/j.amjhyper.2005.06.014.CrossRefPubMed Mahmud A, Feely J: Adiponectin and arterial stiffness. Am J Hypertens. 2005, 18: 1543-1548. 10.1016/j.amjhyper.2005.06.014.CrossRefPubMed
24.
go back to reference Park JS, Kang SA, Yoo JS, Ahn CW, Cha BS, Kim KR, Lee HC: Association between gamma-glutamyltransferase, adiponectin and arterial stiffness. J Atherosclerosis Thromb. 2012, 19: 90-97. 10.5551/jat.9779.CrossRef Park JS, Kang SA, Yoo JS, Ahn CW, Cha BS, Kim KR, Lee HC: Association between gamma-glutamyltransferase, adiponectin and arterial stiffness. J Atherosclerosis Thromb. 2012, 19: 90-97. 10.5551/jat.9779.CrossRef
25.
go back to reference Sugawara J, Hayashi K, Yokoi T, Cortez-Cooper MY, DeVan AE, Anton MA, Tanaka H: Brachial-ankle pulse wave velocity: an index of central arterial stiffness?. J Hum Hypertens. 2005, 19: 401-406. 10.1038/sj.jhh.1001838.CrossRefPubMed Sugawara J, Hayashi K, Yokoi T, Cortez-Cooper MY, DeVan AE, Anton MA, Tanaka H: Brachial-ankle pulse wave velocity: an index of central arterial stiffness?. J Hum Hypertens. 2005, 19: 401-406. 10.1038/sj.jhh.1001838.CrossRefPubMed
26.
go back to reference Weber T, Auer J, O’Rourke MF, Kvas E, Lassnig E, Berent R, Eber B: Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004, 109: 184-189. 10.1161/01.CIR.0000105767.94169.E3.CrossRefPubMed Weber T, Auer J, O’Rourke MF, Kvas E, Lassnig E, Berent R, Eber B: Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004, 109: 184-189. 10.1161/01.CIR.0000105767.94169.E3.CrossRefPubMed
27.
go back to reference Choi ES, Rhee EJ, Choi JH, Bae JC, Yoo SH, Kim WJ, Park SE, Park CY, Lee WY, Cho YK, et al: The association of brachial-ankle pulse wave velocity with 30-minute post-challenge plasma glucose levels in korean adults with no history of type 2 diabetes. Korean diabetes journal. 2010, 34: 287-293. 10.4093/kdj.2010.34.5.287.PubMedCentralCrossRefPubMed Choi ES, Rhee EJ, Choi JH, Bae JC, Yoo SH, Kim WJ, Park SE, Park CY, Lee WY, Cho YK, et al: The association of brachial-ankle pulse wave velocity with 30-minute post-challenge plasma glucose levels in korean adults with no history of type 2 diabetes. Korean diabetes journal. 2010, 34: 287-293. 10.4093/kdj.2010.34.5.287.PubMedCentralCrossRefPubMed
28.
go back to reference Caselli C, Lionetti V, Cabiati M, Prescimone T, Aquaro GD, Ottaviano V, Bernini F, Mattii L, Del Ry S, Giannessi D: Regional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model. Cardiovasc Diabetol. 2012, 11: 143-10.1186/1475-2840-11-143.PubMedCentralCrossRefPubMed Caselli C, Lionetti V, Cabiati M, Prescimone T, Aquaro GD, Ottaviano V, Bernini F, Mattii L, Del Ry S, Giannessi D: Regional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model. Cardiovasc Diabetol. 2012, 11: 143-10.1186/1475-2840-11-143.PubMedCentralCrossRefPubMed
29.
go back to reference Baldasseroni S, Antenore A, Di Serio C, Orso F, Lonetto G, Bartoli N, Foschini A, Marella A, Pratesi A, Scarantino S, et al: Adiponectin, diabetes and ischemic heart failure: a challenging relationship. Cardiovasc Diabetol. 2012, 11: 151-10.1186/1475-2840-11-151.PubMedCentralCrossRefPubMed Baldasseroni S, Antenore A, Di Serio C, Orso F, Lonetto G, Bartoli N, Foschini A, Marella A, Pratesi A, Scarantino S, et al: Adiponectin, diabetes and ischemic heart failure: a challenging relationship. Cardiovasc Diabetol. 2012, 11: 151-10.1186/1475-2840-11-151.PubMedCentralCrossRefPubMed
30.
go back to reference Seino Y, Hirose H, Saito I, Itoh H: High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabol Clin Exp. 2007, 56: 1493-1499. 10.1016/j.metabol.2007.06.015.CrossRef Seino Y, Hirose H, Saito I, Itoh H: High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabol Clin Exp. 2007, 56: 1493-1499. 10.1016/j.metabol.2007.06.015.CrossRef
Metadata
Title
Urinary adiponectin concentration is positively associated with micro- and macro-vascular complications
Authors
Won Seon Jeon
Ji Woo Park
Namseok Lee
Se Eun Park
Eun Jung Rhee
Won Young Lee
Ki Won Oh
Sung Woo Park
Cheol-Young Park
Byung-Soo Youn
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2013
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-12-137

Other articles of this Issue 1/2013

Cardiovascular Diabetology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine